Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production

被引:116
作者
Bozec, Aline [1 ]
Bakiri, Latifa [1 ]
Jimenez, Maria [1 ]
Schinke, Thorsten [2 ]
Amling, Michael [2 ]
Wagner, Erwin F. [1 ]
机构
[1] Spanish Natl Canc Ctr, Canc Cell Biol Program, BBVA Fdn, Genes Dev & Dis Grp, E-28029 Madrid, Spain
[2] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany
基金
欧洲研究理事会;
关键词
MOUSE OSTEOCALCIN GENE; OSTEOSARCOMA CELL-LINE; GROWTH-FACTOR-BETA; TRANSGENIC MICE; IN-VITRO; EXPRESSION; PROMOTER; MASS; ADIPOGENESIS; ACTIVATOR;
D O I
10.1083/jcb.201002111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T he activator protein-1 (AP-1) transcription factor complex, in particular the Fos proteins, is an important regulator of bone homeostasis. Fra-2 (Fosl2), a Fos-related protein of the AP-1 family, is expressed in bone cells, and newborn mice lacking Fra-2 exhibit defects in chondrocytes and osteoclasts. Here we show that Fra-2-deficient osteoblasts display a differentiation defect both in vivo and in vitro. Moreover, Fra-2-overexpressing mice are osteosclerotic because of increased differentiation of osteoblasts, which appears to be cell autonomous. Importantly, the osteoblast-specific osteocalcin (Oc) gene and collagen1 alpha 2 (col1 alpha 2) are transcriptional targets of Fra-2 in both murine and human bone cells. In addition, Fra-2, Oc, and col1 are expressed in stromal cells of human chondroblastic and osteoblastic osteosarcomas (Os's) as well as during osteoblast differentiation of human Os cell lines. These findings reveal a novel function of Fra-2/AP-1 as a positive regulator of bone and matrix formation in mice and humans.
引用
收藏
页码:1093 / 1106
页数:14
相关论文
共 47 条
  • [1] Promoter specificity and biological activity of tethered AP-1 dimers
    Bakiri, L
    Matsuo, K
    Wisniewska, M
    Wagner, EF
    Yaniv, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) : 4952 - 4964
  • [2] Impaired intervertebral disc formation in the absence of Jun
    Behrens, A
    Haigh, J
    Mechta-Grigoriou, F
    Nagy, A
    Yaniv, M
    Wagner, EF
    [J]. DEVELOPMENT, 2003, 130 (01): : 103 - 109
  • [3] Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO
  • [4] 2-F
  • [5] Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
    Bozec, Aline
    Bakiri, Latifa
    Hoebertz, Astrid
    Eferl, Robert
    Schilling, Arndt F.
    Komnenovic, Vukoslav
    Scheuch, Harald
    Priemel, Matthias
    Stewart, Colin L.
    Amling, Michael
    Wagner, Erwin F.
    [J]. NATURE, 2008, 454 (7201) : 221 - U61
  • [6] In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum
    Bruserud, O
    Tronstad, KJ
    Berge, R
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (06) : 377 - 384
  • [7] REQUIREMENTS FOR TRANSFORMING GROWTH-FACTOR-BETA REGULATION OF THE PRO-ALPHA-2(I) COLLAGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTERS
    CHANG, E
    GOLDBERG, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) : 4473 - 4477
  • [8] Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone
    Chien, KR
    Karsenty, G
    [J]. CELL, 2005, 120 (04) : 533 - 544
  • [9] An AP-1 binding sequence is essential for regulation of the human alpha 2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta
    Chung, KY
    Agarwal, A
    Uitto, J
    Mauviel, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3272 - 3278
  • [10] JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
    David, JP
    Sabapathy, K
    Hoffmann, O
    Idarraga, MH
    Wagner, EF
    [J]. JOURNAL OF CELL SCIENCE, 2002, 115 (22) : 4317 - 4325